Richard Mckilligan serves as Executive at Genesis Biopharma, Inc, where they oversee executive responsibilities. Since joining the company, Richard Mckilligan has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 29, 2011 involved transacting 1,500,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 29, 2011 | GNBP | $0 | Other | 1,500,000 | $N/A | Discretionary |
Richard Mckilligan currently holds 1,220,016 shares of Genesis Biopharma, Inc (GNBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Mckilligan has been a net neutral trader of GNBP stock. They have purchased $0 and sold $0 worth of shares.
Richard Mckilligan's most recent insider trade was on Mar 29, 2011, when they sold 1,500,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted